Discover 1,900 paid clinical trials in Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Virginia provides numerous opportunities for both healthy volunteers and people with specific medical conditions to participate in paid medical research. Major research centers in Richmond, Virginia Beach, and Norfolk are actively seeking participants, offering access to innovative treatments and advanced care.
Filter
1
Filter results
Results: 1,900
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
for
Acute Myeloid Leukemia (AML)
Location: Boston MA, Worcester MA, Hartford CT, New Haven CT,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT07007312
Phase 3, Recruiting
A Hospital-based Intervention for Youth Injured Through Violence
for
Violence
Location: Richmond VA
Sponsor: Virginia Commonwealth University
Sex: All
Age: 13 - 17
Code: NCT07475247
Recruiting
Alleviant ALLAY-HFrEF Study
for
Heart Failure
Location: Boston MA, Quebec, New York NY, Montreal, Englewood NJ,
Sponsor: Alleviant Medical, Inc.
Sex: All
Age: 18+
Code: NCT06812533
Recruiting
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Providence RI, New Haven CT, Lebanon NH, Bay Shore NY,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06890338
Phase 2, Recruiting
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
for
Non-alcoholic Fatty Liver Disease
Location: Quebec, New York NY, Norfolk VA, Morehead City NC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07221227
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
for
Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
Location: Washington D.C. DC, Fairfax VA, Plantation FL,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT07407933
Phase 1, Phase 2, Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
for
Metastatic Castration-Resistant Prostate Cancer
Location: New Haven CT, Myrtle Beach SC, Charlottesville VA,
Sponsor: Kyntra Bio
Sex: Male
Age: 18+
Code: NCT06842498
Phase 2, Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Hartford CT, Sherbrooke, New York NY, Montreal,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase 3, Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Halifax, Boston MA, New Haven CT, Quebec, Manhasset NY,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase 3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Flushing NY, East Orange NJ, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase 3, Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Boston MA, Hackensack NJ, Morristown NJ, Greenville NC,
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06947928
Phase 2, Phase 3, Recruiting
Early Screening and Treatment of Heart Complication in Sickle Cell Disease
for
Sickle Cell Disease
Location: Falls Church VA, Fairfax VA
Sponsor: Inova Health Care Services
Sex: All
Age: 18+
Code: NCT07023666
Phase 2, Recruiting
Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia
Location: Bethesda MD, Charlottesville VA, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06965114
Phase 1, Phase 2, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
for
Urothelial Cancer, Bladder Cancer
Location: Norfolk VA, Chapel Hill NC, Grand Rapids MI,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07129993
Phase 2, Phase 3, Recruiting
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: New Haven CT, New York NY, Philadelphia PA, Fairfax VA,
Sponsor: EvolveImmune United, Inc
Sex: All
Age: 18+
Code: NCT07217171
Phase 1, Recruiting
First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies
for
Participants With Advanced Solid Tumor Malignancies
Location: Fairfax VA, Grand Rapids MI, Houston TX, San Antonio TX,
Sponsor: VelaVigo Bio Inc
Sex: All
Age: 18+
Code: NCT07136779
Phase 1, Phase 2, Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Acute Migraine
Location: Boston MA, Waltham MA, Waterbury CT, Commack NY,
Sponsor: TriGemX Bio, Inc.
Sex: All
Age: 18+
Code: NCT07674654
Phase 3, Recruiting
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New York NY, Fairfax VA, Huntersville NC,